Process for manufacturing device with dispersion zone

• US 4,285,987 A
• Filed: 11/01/1979
• Issued: 08/25/1981
• Est. Priority Date: 10/23/1978
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Ayer, Atul D., Theeuwes, Felix
• Primary Examiner(s): Silverberg, Sam
• Application Number:
  US06/090,492
• Time in Patent Office: 663 Days
• Field of Search: 427/3, 424/19, 424/2, 128/260
• US Class Current: 427/2.16
• CPC Class Codes: A61K 9/0004 Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Abstract

An osmotic system is disclosed for dispensing a beneficial agent. The system comprises (1) a first wall of a semipermeable material that surrounds a compartment containing a drug formulation, and has a passageway through the wall for releasing agent from the compartment, (2) a second wall positioned distant from the first wall, said second wall a microporous or hydrogel material that extends around the first wall, and (3) a distribution zone interposed between the first and second wall and initially housing a compound soluble in an external fluid that enters the system.

In operation, agent is dispensed from the system by fluid passing through the second wall into the zone from which fluid is further being imbibed through the first wall into the compartment forming a solution that is released through the passageway into the zone, and then through the second wall to the exterior of the system.

Claims

1. A process for manufacturing a drug delivery device, which process comprises the steps of:

(a) pressing a drug formulation into a shaped, solid mass;

(b) coating the mass with a composition comprising a semipermeable polymer permeable to the passage of fluid and impermeable to the passage of drug to form a semipermeable wall surrounding a compartment housing the formulation;

(c) drilling an outlet passageway in the semipermeable wall of a predetermined size for osmotically pumping the formulation through the passageway;

(d) coating the semipermeable wall with a layer of a member soluble in fluid that enters the device and is selected from the group consisting of a salt, a carbohydrate, and mixtures thereof, which layer separates the semipermeable wall from a microporous wall, said microporous wall formed by;

(e) coating the layer with a composition comprising a microporous polymer to form a microporous wall surrounding the layer, thereby forming the device.

2. The process for manufacturing the drug delivery device of claim 1 wherein the device is shaped, sized and adapted for delivering the drug formulation in an ano-rectal canal.

3. The process for manufacturing the drug delivery device of claim 1 wherein the device is shaped, sized and adapted for delivering the drug formulation in a vagina.

4. The process for manufacturing the drug delivery device of claim 1 wherein the device is shaped, sized and adapted for delivering the drug formulation in a gastrointestinal tract.

5. The process for manufacturing the drug delivery device of claim 1 wherein the semipermeable wall is coated with a layer of salt by dipping the wall into a salt solution.

6. The process for manufacturing the drug delivery device of claim 1 wherein the coating process for forming the walls and the layer is an air suspension coating process.

7. The process for manufacturing the drug delivery device of claim 1 wherein the coating process for forming the walls and the layer uses a member selected from the group consisting of organic and inorganic solvents, and mixtures thereof.

8. The process for manufacturing the drug delivery device of claim 1 wherein the composition comprising the microporous polymer has a pore-forming agent mixed therein.

9. A process for manufacturing a drug delivery device which process comprises the steps of:

(a) pressing a drug formulation into a shaped, solid mass;

(b) coating the mass with a composition comprising a semipermeable polymer permeable to the passage of fluid and impermeable to the passage of drug to form a semipermeable wall that surrounds a compartment housing the formulation;

(c) drilling an outlet passageway in the semipermeable wall of a predetermined size for osmotically pumping the formulation through the passageway;

(d) coating the semipermeable wall with a layer of a member soluble in fluid that enters the device and is selected from the group consisting of a salt, a carbohydrate and mixtures thereof, which layer separates the semipermeable wall from a hydrogel wall, said latter wall formed by;

(e) coating the layer with a hydrogel to form a hydrogel wall surrounding the layer, thereby forming the device.

10. The process for manufacturing the drug delivery device of claim 9 wherein the device is shaped, sized and adapted for delivering the drug formulation in an ano-rectal canal.

11. The process for manufacturing the drug delivery device of claim 9 wherein the device is shaped, sized and adapted for delivering the drug formulations in a vagina.

12. The process for manufacturing the drug delivery device of claim 9 wherein the device is shaped, sized and adapted for delivering the drug formulation in a gastrointestinal tract.

13. The process for manufacturing the drug delivery device of claim 9 wherein semipermeable wall is coated with a layer of salt by dipping the wall into a salt solution.

14. The process for manufacturing the drug delivery device of claim 9 wherein the coating process for forming the walls and the layer is an air suspension coating process.

15. The process for manufacturing the drug delivery device of claim 9 wherein the coating process for forming the walls and the layer uses a member selected from the group consisting of organic and inorganic solvents, and mixtures thereof.